256 related articles for article (PubMed ID: 9933286)
1. Effects of tirilazad mesylate on vasospasm and phospholipid hydroperoxides in a primate model of subarachnoid hemorrhage.
Suzuki H; Kanamaru K; Kuroki M; Sun H; Waga S; Miyazawa T
Stroke; 1999 Feb; 30(2):450-5; discussion 455-6. PubMed ID: 9933286
[TBL] [Abstract][Full Text] [Related]
2. Effects of nitroglycerin on vasospasm and cyclic nucleotides in a primate model of subarachnoid hemorrhage.
Nakao K; Murata H; Kanamaru K; Waga S
Stroke; 1996 Oct; 27(10):1882-7; discussion 1887-8. PubMed ID: 8841348
[TBL] [Abstract][Full Text] [Related]
3. Effects of unilateral intrathecal administrations of low dose tissue-type plasminogen activator on clot lysis, vasospasm and brain phospholipid hydroperoxidation in a primate model of bilateral subarachnoid hemorrhage.
Suzuki H; Kanamaru K; Kuroki M; Sun H; Waga S; Miyazawa T
Neurol Res; 1998 Oct; 20(7):625-31. PubMed ID: 9785591
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
Lanzino G; Kassell NF; Dorsch NW; Pasqualin A; Brandt L; Schmiedek P; Truskowski LL; Alves WM
J Neurosurg; 1999 Jun; 90(6):1011-7. PubMed ID: 10350245
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America.
Haley EC; Kassell NF; Apperson-Hansen C; Maile MH; Alves WM
J Neurosurg; 1997 Mar; 86(3):467-74. PubMed ID: 9046304
[TBL] [Abstract][Full Text] [Related]
6. Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot.
Kanamaru K; Weir BK; Simpson I; Witbeck T; Grace M
J Neurosurg; 1991 Mar; 74(3):454-9. PubMed ID: 1993911
[TBL] [Abstract][Full Text] [Related]
7. Effects of new 21-aminosteroid tirilazad mesylate (U74006F) on chronic cerebral vasospasm in a "two-hemorrhage" model of beagle dogs.
Matsui T; Asano T
Neurosurgery; 1994 Jun; 34(6):1035-9; discussion 1039. PubMed ID: 8084388
[TBL] [Abstract][Full Text] [Related]
8. The effect of timing of clot removal on chronic vasospasm in a primate model.
Handa Y; Weir BK; Nosko M; Mosewich R; Tsuji T; Grace M
J Neurosurg; 1987 Oct; 67(4):558-64. PubMed ID: 3655894
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and mechanisms of action of the cytoprotective lipid peroxidation inhibitor tirilazad mesylate in subarachnoid haemorrhage.
Hall ED
Eur J Anaesthesiol; 1996 May; 13(3):279-89. PubMed ID: 8737119
[TBL] [Abstract][Full Text] [Related]
10. U74389G prevents vasospasm after subarachnoid hemorrhage in dogs.
Macdonald RL; Bassiouny M; Johns L; Sajdak M; Marton LS; Weir BK; Hall ED; Andrus PK
Neurosurgery; 1998 Jun; 42(6):1339-45; discussion 1345-6. PubMed ID: 9632194
[TBL] [Abstract][Full Text] [Related]
11. Cytoskeletal and extracellular matrix proteins in cerebral arteries following subarachnoid hemorrhage in monkeys.
Macdonald RL; Weir BK; Young JD; Grace MG
J Neurosurg; 1992 Jan; 76(1):81-90. PubMed ID: 1727173
[TBL] [Abstract][Full Text] [Related]
12. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage.
Pluta RM; Oldfield EH; Boock RJ
J Neurosurg; 1997 Nov; 87(5):746-51. PubMed ID: 9347984
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.
Haley EC; Kassell NF; Alves WM; Weir BK; Hansen CA
J Neurosurg; 1995 May; 82(5):786-90. PubMed ID: 7714603
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America.
Lanzino G; Kassell NF
J Neurosurg; 1999 Jun; 90(6):1018-24. PubMed ID: 10350246
[TBL] [Abstract][Full Text] [Related]
15. Effect of cyclosporine on the development of cerebral vasospasm in a primate model.
Handa Y; Hayashi M; Takeuchi H; Kobayashi H; Kawano H; Kabuto M
Neurosurgery; 1991 Mar; 28(3):380-5; discussion 385-6. PubMed ID: 2011219
[TBL] [Abstract][Full Text] [Related]
16. Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage.
Jang YG; Ilodigwe D; Macdonald RL
Neurocrit Care; 2009; 10(1):141-7. PubMed ID: 18810661
[TBL] [Abstract][Full Text] [Related]
17. Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage.
Zuccarello M; Marsch JT; Schmitt G; Woodward J; Anderson DK
J Neurosurg; 1989 Jul; 71(1):98-104. PubMed ID: 2661744
[TBL] [Abstract][Full Text] [Related]
18. Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm.
Willette RN; Zhang H; Mitchell MP; Sauermelch CF; Ohlstein EH; Sulpizio AC
Stroke; 1994 Dec; 25(12):2450-5; discussion 2456. PubMed ID: 7974589
[TBL] [Abstract][Full Text] [Related]
19. Vasospasm in monkeys resolves because of loss of and encasement of subarachnoid blood clot.
Zhang ZD; Yamini B; Komuro T; Ono S; Johns L; Marton LS; Weir B; Macdonald RL
Stroke; 2001 Aug; 32(8):1868-74. PubMed ID: 11486119
[TBL] [Abstract][Full Text] [Related]
20. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to L-arginine infusion after subarachnoid hemorrhage.
Pluta RM; Afshar JK; Thompson BG; Boock RJ; Harvey-White J; Oldfield EH
J Neurosurg; 2000 Jan; 92(1):121-6. PubMed ID: 10616090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
